Viatris Inc. (VTRS)
9.15
-0.29 (-3.07%)
At close: Mar 21, 2025, 3:59 PM
Viatris Inc. Revenue Breakdown
| Quarter | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Brands Revenue | 2.36B | 2.31B | 2.4B | 2.53B | 2.44B | 2.42B | 2.31B | 2.54B | 2.48B | 2.55B | 2.61B | 2.8B | 2.7B | 2.72B |
| Brands Revenue Growth | +2.30% | -3.88% | -5.16% | +3.62% | +1.01% | +4.68% | -8.98% | +2.30% | -2.78% | -2.21% | -6.82% | +3.75% | -0.84% | n/a |
| Generics Revenue | 1.38B | 1.34B | 1.87B | 1.23B | 1.33B | 1.16B | 1.31B | 1.21B | 1.27B | 1.23B | 1.37B | 1.39B | 1.53B | 1.35B |
| Generics Revenue Growth | +2.34% | -28.23% | +52.74% | -7.48% | +14.01% | -11.07% | +8.33% | -4.78% | +2.77% | -10.04% | -1.04% | -9.28% | +13.41% | n/a |
Revenue by Geography
| Quarter | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|
| Developed Markets Segment Revenue | 9.25B | 9.77B | 10.43B | 8.51B |
| Developed Markets Segment Revenue Growth | -5.29% | -6.33% | +22.53% | n/a |
| Emerging Markets Segment Revenue | 2.55B | 2.62B | 3.14B | 1.85B |
| Emerging Markets Segment Revenue Growth | -2.45% | -16.83% | +69.64% | n/a |
| Greater China Segment Revenue | 2.16B | 2.2B | 2.21B | 259.9M |
| Greater China Segment Revenue Growth | -1.85% | -0.52% | +751.40% | n/a |
| Japan, Australia And New Zealand Segment Revenue | 1.42B | 1.63B | 2.03B | 1.2B |
| Japan, Australia And New Zealand Segment Revenue Growth | -12.74% | -19.48% | +69.61% | n/a |
Operating Expense Breakdown
| Quarter | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 27, 2020 | Jun 28, 2020 | Mar 29, 2020 | Dec 31, 2019 | Sep 29, 2019 | Jun 29, 2019 | Mar 30, 2019 | Dec 30, 2018 | Sep 29, 2018 | Jun 29, 2018 | Mar 30, 2018 | Dec 30, 2017 | Sep 29, 2017 | Jun 29, 2017 | Mar 30, 2017 | Dec 30, 2016 | Sep 29, 2016 | Jun 29, 2016 | Mar 30, 2016 | Dec 30, 2015 | Sep 29, 2015 | Jun 29, 2015 | Mar 30, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1B | 928.9M | 1.02B | 1.61B | 1.05B | 1.03B | 958.9M | 913.4M | 914.5M | 857.5M | 828.5M | 979.9M | 1.01B | 1.15B | 972.4M | 1.54B | 588M | 588.9M | 586.4M | 681M | 582.1M | 657.8M | 586.4M | 622.4M | 578M | 591.2M | 605.7M | 527.7M | 660.1M | 617.7M | 600.8M | 454.1M | 658.9M | 574.2M | 542.5M | 362.3M | 528.5M | 539.3M | 475.4M |
| Selling, General, and Administrative Revenue Growth | +8.02% | -8.71% | -36.64% | +52.43% | +2.09% | +7.61% | +4.98% | -0.12% | +6.65% | +3.50% | -15.45% | -2.80% | -12.13% | +17.98% | -36.71% | +161.29% | -0.15% | +0.43% | -13.89% | +16.99% | -11.51% | +12.18% | -5.78% | +7.68% | -2.23% | -2.39% | +14.78% | -20.06% | +6.86% | +2.81% | +32.31% | -31.08% | +14.75% | +5.84% | +49.74% | -31.45% | -2.00% | +13.44% | n/a |
| Research and Development Revenue | 198.4M | 196.3M | 199.7M | 202.8M | 211.2M | 208.3M | 182.9M | 219.4M | 174.9M | 162.6M | 142.3M | 286.6M | 152.1M | 147.7M | 184.1M | 192.2M | 129.8M | 156.3M | 114.2M | 260.6M | 167.9M | 147.6M | 202.1M | 179M | 159.6M | 248.7M | 234.9M | 277M | 182.3M | 181.1M | 217.5M | 194.6M | 199.1M | 179.5M | 253.6M | 159M | 174.8M | 168.2M | 169.9M |
| Research and Development Revenue Growth | +1.07% | -1.70% | -1.53% | -3.98% | +1.39% | +13.89% | -16.64% | +25.44% | +7.56% | +14.27% | -50.35% | +88.43% | +2.98% | -19.77% | -4.21% | +48.07% | -16.95% | +36.87% | -56.18% | +55.21% | +13.75% | -26.97% | +12.91% | +12.16% | -35.83% | +5.87% | -15.20% | +51.95% | +0.66% | -16.74% | +11.77% | -2.26% | +10.92% | -29.22% | +59.50% | -9.04% | +3.92% | -1.00% | n/a |